Cerebral Venous Sinus Thrombosis during Chemotherapy with Capecitabine: Case Presentation and Strategy for Anticoagulation.

Abstract Cerebral venous sinus thromboses (CVST) are rare but may be associated to life-threatening prognosis and prolonged disability. We report a case of CVST during chemotherapy with capecitabine in a patient with metastatic breast cancer without any additional risk factors. She presented with headache, depressed consciousness and sensorial aphasia. Several cerebral venous sinuses were involved, with associated deep venous extension, brain infarcts and secondary parenchymal bleeding. Evolution after anticoagulation with heparin during the acute phase and long-term rivaroxaban has been favorable, with full neurologic recovery and absence of thrombotic relapses and bleedings. Furthermore, chemotherapy with capecitabine was restarted and is maintained so far, with a durable response and no additional complications. Keywords: Cerebral venous sinus thrombosis. Breast cancer. Chemotherapy. Capecitabine.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-09
DOI
https://doi.org/10.5281/zenodo.17404119
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cerebral Venous Sinus Thrombosis during Chemotherapy with Capecitabine: Case Presentation and Strategy for Anticoagulation.

Zenodo (CERN European Organization for Nuclear Research)
Cerebral Venous Sinus Thrombosis
article

Cerebral Venous Sinus Thrombosis during Chemotherapy with Capecitabine: Case Presentation and Strategy for Anticoagulation.

article en

Abstract

Abstract Cerebral venous sinus thromboses (CVST) are rare but may be associated to life-threatening prognosis and prolonged disability. We report a case of CVST during chemotherapy with capecitabine in a patient with metastatic breast cancer without any additional risk factors. She presented with headache, depressed consciousness and sensorial aphasia. Several cerebral venous sinuses were involved, with associated deep venous extension, brain infarcts and secondary parenchymal bleeding. Evolution after anticoagulation with heparin during the acute phase and long-term rivaroxaban has been favorable, with full neurologic recovery and absence of thrombotic relapses and bleedings. Furthermore, chemotherapy with capecitabine was restarted and is maintained so far, with a durable response and no additional complications. Keywords: Cerebral venous sinus thrombosis. Breast cancer. Chemotherapy. Capecitabine.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 37%
Cerebral Venous Sinus Thrombosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.